Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What is GLEEVEC and what is the approved indication?

Approved Gleevec indication
0
Posted

What is GLEEVEC and what is the approved indication?

0

Gleevec is a therapy that targets the main cause of Chronic Myeloid Leukemia (CML) – the Philadelphia chromosome. Gleevec is indicated for the treatment of newly diagnosed adult patients with Philadelphia chromosome-positive CML in chronic phase. Follow Gleevec is also indicated for the treatment of patients with Philadelphia chromosome-positive CML in blast crisis, accelerated phase, or in chronic phase after failure on interferon-alpha therapy. Gleevec is also indicated for the treatment of pediatric patients with Ph+ CML in chronic phase who are newly diagnosed or whose disease has recurred after stem cell transplant or who are resistant to interferon-alpha therapy. There are no controlled trials in pediatric patients demonstrating a clinical benefit, such as improvement in disease-related symptoms or increased survival. Gleevec is also indicated for adult patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), adult patients wit

Related Questions

Thanksgiving questions

*Sadly, we had to bring back ads too. Hopefully more targeted.